Silvant Capital Management LLC Akero Therapeutics, Inc. Transaction History

Silvant Capital Management LLC

  • $2.35 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 09, 2022
SELL
$10.15 - $34.05 $19,356 - $64,933
-1,907 Reduced 45.28%
2,305 $78,000
Q4 2021

Feb 07, 2022
SELL
$19.87 - $26.24 $5,364 - $7,084
-270 Reduced 6.02%
4,212 $89,000
Q3 2020

Nov 09, 2020
BUY
$30.79 - $39.92 $51,850 - $67,225
1,684 Added 60.19%
4,482 $138,000
Q2 2020

Aug 11, 2020
BUY
$19.25 - $26.76 $53,861 - $74,874
2,798 New
2,798 $70,000

Others Institutions Holding AKRO

# of Institutions
210
Shares Held
74.3M
Call Options Held
321K
Put Options Held
558K
View Full List

About Akero Therapeutics, Inc.

AKRO Quotes by TradingView
  • Ticker AKRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,417,600
  • Market Cap $2.1B
  • Description
  • Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...
More about AKRO
Track This Portfolio

Track Silvant Capital Management LLC Portfolio

Follow Silvant Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvant Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvant Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email